Medullary Thyroid Carcinoma

Medullary thyroid carcinoma is a rare type of thyroid cancer.

Medullary thyroid carcinoma arises from the parafollicular cells (C cells) that produce the hormone calcitonin. Medullary thyroid carcinoma can occur sporadically or as part of hereditary syndromes.

Learn more about medullary thyroid carcinoma, including its definition, causes, symptoms, diagnosis, treatment, and potential risks and complications.

What is medullary thyroid carcinoma?

Medullary thyroid carcinoma is a malignancy of the thyroid gland originating from the parafollicular cells, which are responsible for producing calcitonin, a hormone involved in calcium regulation. Medullary thyroid carcinoma accounts for about 3-4% of all thyroid cancers and can be more aggressive than other types of thyroid cancer.

Types of medullary thyroid carcinoma

Sporadic medullary thyroid carcinoma

• Description: The most common form, accounting for about 75% of cases. It usually occurs in individuals without a family history of the disease.
• Onset: Typically diagnosed in adults.

Hereditary medullary thyroid carcinoma

• Description: Accounts for about 25% of cases and is associated with genetic syndromes such as Multiple Endocrine Neoplasia type 2 (MEN2).
• Subtypes: Includes MEN2A, MEN2B, and familial medullary thyroid carcinoma (FMTC).
• Onset: Often diagnosed at a younger age and may affect multiple family members.

Causes of medullary thyroid carcinoma

Genetic mutations

• RET proto-oncogene: Mutations in the RET gene are linked to both sporadic and hereditary medullary thyroid carcinoma. In hereditary cases, these mutations are inherited in an autosomal dominant pattern.

Risk factors

• Family history: A family history of medullary thyroid carcinoma or MEN2 significantly increases the risk of developing the disease.
• Genetic syndromes: Particular genetic syndromes, such as MEN2A, MEN2B, and FMTC, are associated with a higher risk of medullary thyroid carcinoma.

Symptoms of medullary thyroid carcinoma

Early-stage symptoms

• Neck mass: A lump or nodule in the neck.
• Swelling: Enlargement of the thyroid gland.
• Hoarseness: Changes in the voice due to pressure on the vocal cords.

Learn more about thyroid nodules>>

Advanced-stage symptoms

• Difficulty swallowing: Dysphagia due to compression of the esophagus.
• Difficulty breathing: Dyspnea caused by tracheal compression.
• Persistent cough: Due to irritation of the trachea or esophagus.
• Symptoms of metastasis: Bone pain, weight loss, and other symptoms related to the spread of cancer to other organs.

Hormonal symptoms

• Diarrhea: Caused by high levels of calcitonin.
• Flushing: Episodes of redness and warmth, particularly in the face, associated with hormone release.

Diagnosis of medullary thyroid carcinoma

Medical history and physical examination

• Symptom assessment: Detailed inquiry about the presence and duration of symptoms such as neck mass, hoarseness, and swallowing difficulties.
• Family history: Evaluation of family history to identify patterns of inherited endocrine disorders.

Laboratory tests

• Calcitonin levels: Elevated calcitonin levels in the blood are a key marker for medullary thyroid carcinoma.
• Carcinoembryonic antigen (CEA): Elevated CEA levels can indicate the presence and progression of medullary thyroid carcinoma.
• Genetic testing: Analysis of the RET gene to identify mutations, especially in familial cases.

Imaging studies

• Ultrasound: Imaging of the thyroid gland to assess the size and characteristics of nodules.
• CT scan or MRI: Detailed imaging to visualize the extent of the tumor and detect potential metastases.
• Radioactive iodine scan: Though less commonly used for medullary thyroid carcinoma, it may help identify additional thyroid tissue.

Biopsy

• Fine-needle aspiration (FNA): A needle is used to extract cells from the thyroid nodule, which are then examined under a microscope to confirm the presence of cancer cells.

Treatment of medullary thyroid carcinoma

Surgical treatment

• Total thyroidectomy: The primary treatment for medullary thyroid carcinoma, involving the complete removal of the thyroid gland.
• Lymph node dissection: Removal of affected lymph nodes in the neck to prevent the spread of cancer.

Post-surgical management

• Thyroid hormone replacement therapy: Lifelong medication to compensate for the loss of thyroid function and maintain normal hormone levels.
• Monitoring calcitonin and CEA levels: Regular blood tests to monitor for potential recurrence of cancer.

Radiotherapy and chemotherapy

• External beam radiotherapy: May be used in cases where surgery is not entirely effective or feasible.
• Chemotherapy: Less commonly used, but may be considered for advanced or metastatic medullary thyroid carcinoma cases.

Targeted therapy

• Tyrosine kinase inhibitors (TKIs): Targeted drugs like vandetanib and cabozantinib specifically inhibit cancer cell growth and are used for advanced medullary thyroid carcinoma.

Special considerations for hereditary medullary thyroid carcinoma

• Preventive thyroidectomy: For individuals with RET gene mutations, especially children and adolescents, early thyroidectomy may be recommended to prevent the development of medullary thyroid carcinoma.
• Regular screening: Lifelong monitoring and screening for medullary thyroid carcinoma and associated endocrine tumors in individuals with familial RET mutations.

Potential risks and complications

Surgical complications

• Infection: Risk of infection at the surgical site.
• Bleeding: Risk of bleeding during and after surgery.
• Nerve damage: Risk of damage to the recurrent laryngeal nerve, causing voice changes or hoarseness.
• Hypoparathyroidism: Accidental removal or damage to the parathyroid glands, leading to low calcium levels.

Long-term complications

• Cancer recurrence: Risk of medullary thyroid carcinoma recurrence, requiring ongoing monitoring and possible additional treatments.
• Metastasis: Spread of cancer to other parts of the body, such as lymph nodes, liver, lungs, or bones.

Impact on quality of life

• Hormone management: Lifelong need for thyroid hormone replacement therapy and regular monitoring of hormone levels.
• Emotional and psychological impact: Stress and anxiety related to cancer diagnosis, treatment, and long-term follow-up.

Medullary thyroid carcinoma is a rare but significant thyroid cancer that requires timely diagnosis and appropriate treatment.

Comprehensive care, including surgical intervention, post-operative management, and long-term follow-up, is crucial for improving outcomes and quality of life for affected individuals.

If you are diagnosed with medullary thyroid carcinoma or have a family history of the condition, consulting with a specialized medical team will help develop a personalized care plan tailored to your specific needs and circumstances.